As a pharmacy doctor, you will see more consensus on using statins for diabetes patients. We all know the controversy about the ACC/AHA cholesterol guidelines that abandoned LDL goals and recommended specific statin doses instead. Now the American Diabetes Association is following suit and providing similar guidance on when to use a statin in diabetes patients. …
قراءة المزيدAs a clinical pharmacist, people with diabetes will rely on your help to tailor A1c goals and decipher continuous glucose monitoring (CGM) metrics. Continue to emphasize individualizing glycemic goals, explain that a “one-size-fits-all” approach isn’t safe, practical, or recommended... A1c. Rely on A1c to asses…
قراءة المزيدAs a cardiovascular pharmacist, there is an ongoing debate regarding the necessity of aiming for a specific LDL goal. For over a decade, the focus has been on using target DOSES of statins shown to reduce CV risk , rather than titrating to an LDL goal. But there’s been a shift toward a blended approach in recent years. Data comparing specific LDL targets are limited.…
قراءة المزيدAs a hospital pharmacist, you will hear about a new medication finerenone ( Kerendia ) for patients with chronic kidney disease (CKD) due to type 2 diabetes. It's the first "nonsteroidal mineralocorticoid receptor antagonist", and is approved to slow CKD progression and improve CV outcomes in these patients. Finerenone is thought to limit fibrosis and …
قراءة المزيدAs a clinical pharmacist, you should optimize treatment of chronic kidney disease (CKD) in patients With diabetes. Patients with CKD have a much higher rate of hospitalization, especially if they have diabetes. Use a hospital stay to optimize treatment. Ensure patients are on an ACEI or ARB to manage blood pressure (BP) . Continue to us…
قراءة المزيدAs a pharmacy doctor, you will hear buzz about new injectable Mounjaro (tirzepatide), the first "twincretin" for type 2 diabetes . Think of Mounjaro as similar to a glucagon-like peptide-1 (GLP-1) agonist, BUT it’s also a glucose-dependent insulinotropic polypeptide (GIP) agonist. More twincretins are in the works. GL…
قراءة المزيدMetabolic syndrome is a BIG problem and growing. It affects over 25% of adults and 4% of adolescents. It's also called "insulin resistance syndrome" or "syndrome X" or "dysmetabolic syndrome" and even has its own ICD-9 code (see table 1) . New treatment guidelines will focus even more attention on it... …
قراءة المزيدAs a nutrition support pharmacist, you will hear more about using Saxenda for weight loss in adolescents 12 and up, not just in adults. Saxenda will be the first GLP-1 agonist for obesity, that in addition to stimulating insulin release and inhibiting glucagon secretion, slows gastric emptying and increases satiety after eating, (see our Note about Saxenda for weigh…
قراءة المزيدUp to 50% of patients with diabetes develop peripheral neuropathy. Tailor medication selection based on side effects, cost, whether the medication can also treat other conditions, etc. Expect trial and error... Start at low doses and titrate to effect. But set realistic expectations. In general, fewer than 1 in 3 patients will see a 50% decrease in pain with first-l…
قراءة المزيدMany eligible adults with diabetes aren’t on a statin . We know that statins reduce cardiovascular (CV) risk in patients with type 1 or 2 diabetes , and guidelines recommend use. Plus statin use in patients with diabetes age 40 to 75 is a common quality measure. Follow these steps... Think of statins as "automatic" for most …
قراءة المزيدOn WORLD DIABETES DAY (14 November), the question is increasing about what is the best diet to improve blood glucose level. Medical nutrition therapy plays an important role in the management of diabetes, it has a significant impact on T2DM patients. Counseling and education sessions for development of an individualized eating plan according to the metabolic needs of…
قراءة المزيدPatients with type 2 diabetes (T2D) constitute approximately 90%-95% of all patients with diabetes worldwide. In 2013, 382 million adults were diagnosed with diabetes worldwide. This number is expected to grow to 592 million in 2035. About 1 in 3 adults and 1 in 5 adolescents in the U.S. have prediabetes, but most are unaware. Prediabetes is the term used for ind…
قراءة المزيدPatients may ask whether cinnamon is helpful for diabetes . It doesn't seem to help in type 1 diabetes, BUT it may improve insulin sensitivity and lower glucose in patients with type 2 diabetes . Studies are conflicting. But overall, they suggest that using cinnamon supplements for up to 4 months may modestly lower fasting blood glucose in type 2 diabetes b…
قراءة المزيدNPS | Notes in Pharmacy Specialties is a free, open-access, peer-reviewed site focused on pharmacy practice. Articles are immediately accessible, covering clinical pharmacy, pharmaceutical care, health promotion, informatics, and more.
Egypt - Phone: (+20)1210274589
Gmail: abdelwahabward@gmail.com
Social Plugin